← Open Payments lookup

LESLIE YEARTA-BROWN: Open Payments

NPI 1225378524 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$647 in 20 payments from 10 companies in 2025. Trend: 2023 $592 · 2024 $688 · 2025 $647

Food & beverage: $647
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.2$152
Travere Therapeutics, Inc.3$145
AstraZeneca Pharmaceuticals LP5$140
Boehringer Ingelheim Pharmaceuticals, Inc.3$48
Otsuka Pharmaceutical Development & Commercialization, Inc.2$38
Ardelyx, Inc.1$33
GENZYME CORPORATION1$32
Vantive US Healthcare LLC1$29
SCPHARMACEUTICALS INC.1$15
GlaxoSmithKline, LLC.1$15

Products named: TARPEYO, Filspari, FARXIGA, JARDIANCE, LOKELMA, IBSRELA, FABRAZYME, Renal - PD.

Industry payments across MO — which companies pay providers there.